Company Analysis

CorMedix Inc. (CRMD)

Nasdaq: CRMD · Pharmaceutical Preparations · Parsippany, NJ · filing with the SEC since 2007
Grade6.3
◀ Past 4.7● Present 6.8▶ Future 7.4

Who runs CorMedix Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Todisco Joseph
Chief Executive Officer. First filing Mar 2022, latest Feb 6, 2026, 8 filings in all.
Officers reporting now
6
of 11 people with a filing in the last fifteen months
Directors reporting now
5
28 people on the record since 2010
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Blum SusanChief Financial OfficerAug 2025Sep 1, 2026none
Masson ElizabethChief Operating OfficerApr 2018Sep 1, 2026none
Zelnick Kaufman BethChief Legal OfficerDec 2023Sep 1, 2026none
Todisco JosephChief Executive OfficerMar 2022Feb 6, 20261 · $400,000
Lefkowitz Steven WInterim Chief Financial OfcrAug 2011Jan 27, 20261 · $500,000
Seckler Michael DavidChief Commercial OfficerJan 2026Jan 15, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Dillione JanetdirectorAug 2015Sep 18, 20265 · $1.5M
Duncan Gregory ScottdirectorNov 2020Jan 27, 2026none
Dunton Alan WdirectorMar 2019Jan 27, 20261 · $300,000
Kaplan MyrondirectorMay 2016Jan 27, 2026none
Stewart Robert AdirectorApr 2023Jan 27, 2026none
Earlier names on the record17, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton CRMD · research, not advice